CIMC helps HK battle pandemic by offering over 2,000 units of modular buildings
SHENZHEN, China, March 14, 2022 /PRNewswire/ -- CIMC Modular Building System will provide a total of 2,076 units of modular buildings to help Hong Kong fight against the COVID-19 pandemic. Modular transitional house being hoisted Interior of the modular transitional house The modular transitional house, which has just been hoisted, can be transformed into...
Ascletis Announces Further Expansion of Ritonavir Oral Tablet Production Capacity to 530 Million Tablets Per Year
HANGZHOU, China and SHAOXING, China, March 13, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (Ascletis, HKEX: 1672) today announces that it has further expanded its ritonavir oral tablet production capacity to approximately 530 million tablets per year, to meet the potential escalation in the domestic and global demands. Ascletis has taken multiple measures for expansion of the annual ritonavir production capacity,...
Terran Biosciences announces acquisition of a portfolio of novel CNS therapeutics from Concert Pharmaceuticals
NEW YORK, March 11, 2022 /PRNewswire/ -- Terran Biosciences ("Terran"), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has entered into an agreement with Concert Pharmaceuticals ("Concert") to acquire a portfolio of Concert's CNS therapeutics and accompanying intellectual property. These deuterated compounds represent next-generation...
NMPA Clears IND for First T-Cell Receptor (TCR) T Cell Therapy to Treat Hepatitis B virus (HBV) associated hepatocellular carcinoma (HCC)
SINGAPORE, March 11, 2022 /PRNewswire/ -- Singapore-based SCG Cell Therapy Pte Ltd ("SCG"), a leading biotechnology company, today announced that the China National Medical Products Administration (NMPA) has cleared its Investigational New Drug (IND) application for SCG101, the company's first T-cell receptor T-cell therapy targeted hepatitis B viral antigens. SCG101 is the first TCR-T cell therapy approved by the...
Happiness Development Announces $6.7 Million Registered Direct Offering To Support Its Auto Business
NANPING, China, March 11, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ: HAPP) an emerging and diversified company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce sales and e-commerce marketing solutions, and the sales of automobile today announced that it has entered into a securities purchase agreement with certain non-U.S. strategic investors for...
Hong Kong Life launches “VHIS Certified Plans – Fabulous Offer” providing up to 70% First Year Premium Discount and multiple offers
HONG KONG, March 11, 2022 /PRNewswire/ -- Hong Kong Life is dedicated to helping customers enjoy a better life by providing comprehensive and caring products. Hong Kong Life specially presents the "VHIS Certified Plans – Fabulous Offer" to encourage customers to enhance their health protection. From now until 31 March 2022, first 100 customers with successful application for...
Biobot Surgical signs MOU with BEBIG Medical to collaborate on a robotic-guided prostate brachytherapy solution
SINGAPORE, March 11, 2022 /PRNewswire/ -- Biobot Surgical, a robotic-assisted percutaneous surgical systems company, is delighted to announce a MOU with BEBIG Medical, a global provider of radiotherapy products and a brachytherapy leader based in Europe to work together to provide a robotic-guided high dose rate (HDR) brachytherapy solution for prostate cancer treatment. Biobot Surgical developed the iSR'obot Mona...
ALEA LAUNCHES “ALEA FOR WOMEN”
HONG KONG, March 11, 2022 /PRNewswire/ -- Women account for 80% of purchasing decisions in the healthcare industry. Yet, too few insurance solutions are focused on their specific needs. Moreover, when it comes to women's health, available resources and information are often lacking or difficult to access. Alea, where most of the team are women, is...
CYMBIOTIKA EXPANDS PRODUCT OFFERINGS IN AUSTRALIAN MARKET
Top nutritional supplement brand widens access to holistic wellness with eight new products on recently launched Australian site SAN DIEGO, March 11, 2022 /PRNewswire/ -- Cymbiotika, a leading nutritional supplement brand known for creating pure, clinically-backed supplements, today announced the release of eight new products available on its Australian website. Following the...
Gan & Lee Pharmaceuticals Begins First-In-Human Trial in U.S. for Investigational Drug, GZR18
BEIJING and BRIDGEWATER, N.J., March 11, 2022 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), is pleased to announce the first subject has been dosed in our Phase I, double-blinded, randomized, placebo-controlled, sequential, single, ascending dose clinical study in the U.S. for the company's investigational drug, GZR18. GZR18 is...
